Sight Sciences Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.3% | +2.7% | +10.9% | -5.7% | -5.4% | -8.2% | +11.7% | +1.7% | +2.4% | -3.4% | +18.7% | – | |
| – | +3.7% | +0.6% | +8.3% | +7.4% | -22.7% | -3.9% | +23.3% | -9.0% | -4.1% | +4.7% | -26.0% | – | |
| – | -7.8% | +3.1% | +11.4% | -7.8% | -2.0% | -8.9% | +9.9% | +3.7% | +3.4% | -4.6% | +25.9% | – | |
| – | -19.2% | +35.3% | -6.9% | +10.0% | -9.5% | +3.2% | -1.0% | -23.6% | -27.3% | +4.5% | -1.3% | – | |
| – | -18.7% | +23.2% | +0.5% | -12.3% | -2.5% | +7.6% | -2.7% | -8.9% | -12.6% | +41.1% | -15.3% | – | |
| – | -11.9% | +15.2% | -0.6% | -9.2% | +1.3% | +1.6% | -2.4% | -11.2% | -14.5% | +37.0% | -14.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -5.7% | -10.9% | -4.9% | +0.5% | +0.9% | +8.8% | +1.7% | +1.7% | -1.3% | -1.6% | +1.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -87.2% | +70.0% | -11.8% | +1,006.7% | -77.1% | +7.9% | -2.4% | -297.5% | – | +37.5% | +154.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.